31.08.22
Michael Sassano of Somai Pharmaceuticals on To Be Blunt – Episode 117 The Global Cannabis Market and Why Germany is Poised to Lead
Shayda Torabi – YouTube
Michael Sassano of Somai Pharmaceuticals on To Be Blunt
Latest News
Filter by type
Date published
29.08.22
Karma Koala Podcast Episode 92: Professor June McLaughlin, Kim Stuck Allay Consulting, Michael Sassano Somai Pharmaceuticals & Amy McDougal Clearsources
Spotify
Heather Allman talks with Michael Sassano of SOMAÍ Pharmaceuticals LTD about recent regulatory changes, the differences between Europe and US when it comes to GMP licensing.
27.08.22
Interview Time! Michael Sassano – CEO of Somai Pharmaceuticals
YouTube – Ask GenieNansea
In this episode, SOMAÍ’s CEO, Michael Sassano, explains how he got involved in the industry, talks about his experience in the States so far and about SOMAÍ Pharmaceuticals.
22.08.22
With Extracts Expected To Achieve A ‘50% Share Of The EU Cannabis Market’ In The Next Few Years, Who Is Currently Leading The Field?
BusinessCann
Michael Sassano, CEO of international cannabis manufacturer Somai Pharmaceuticals, explores the state of cannabis extract manufacturing in Europe and who is currently leading the pack.
16.08.22
The Case for THCA and Other Minor Cannabinoids
Cannabis Science and Technology
In this article, Somai’s R&D Director, Anthony DeMeo, examines why we should be studying cannabinoids beyond THC and CBD to explore their potential medical value.
03.08.22
Consider Cannabis – Cannabis and International Markets
Consider Cannabis
02.08.22
Michael Sassano & Antonio Guedelha: GMP #12: Optimizing Pharmaceutical Good Manufacturing Processes
Cannabis Law Report
Manufacturing process optimization aims to increase productivity, decrease operational costs, and make the manufacturing process more robust via a more stable, controlled analysis with fewer errors. We will concentrate on step-by-step improvements using the Plan, Do, Check, and Act (PDSA) methodology.
02.08.22
SOMAÍ PHARMACEUTICALS – MEDICAL CANNABIS PRODUCTS MANUFACTURING FACILITY
Anteprojectos
Como primeiro investimento da SOMAÍ em Portugal, foi apresentado um edifício com licença de armazém, com a pretensão de conversão do mesmo em edifício de uso industrial. Dado que as suas características já tinham a utilização mista de escritórios, zonas sociais com balneários e vestiários, o desafio era reconverter o edifício para uma nova utilização e com base nas normas legais em vigor para o uso proposto e as necessidades da atividade.
28.07.22
Here Weed Go – It’s Pharmaceutical (in Europe)
Omny Studio
Today’s episode has a decidedly European flavor: my guest is Michael Sassano, the Founder, Chairman and CEO of Somai Pharmaceuticals, a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal.